Regulation of Langerhans cell function via blood borne factor(s)

Journal of Dermatological Science

Volumn 12, Issue 3, 1996, Pages 263-274

  Xie, Yong ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Functional transformation; GM CSF; Langerhans cells; Mixed epidermal cell lymphocyte reaction; Serum factors

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COW; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030246917     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-1811(95)00499-8     Document Type: Article

References (24)

1. [1] Rowden O, Lewis MO, Sullivan AL: 1a antigen expression on epidermal Langerhans cells. Nature (Lond) 268: 248-252, 1977.
2. [2] Silberberg I, Baer RI: The role of the Langerhans cell in allergic contact hypersensitivity. J Invest Dermatol 66: 210-217, 1976.
3. [3] Streilein JW: Lymphocyte traffic. T-cell malignancies and the skin. J Invest Dermatol 71: 167-171, 1978.
4. [4] Streilein JW: Skin associated lymphoid tissues (SALT): the next generation, in The Skin Immune System (SIS). Edited by J Bos. CRC Press, Boca Raton, FL, 1990, pp. 26-39.
5. [5] Stingl G, Katz SI, Clement L, Green I, Shevach EM: Immunologic functions of 1a-bearing epidermal Langerhans cells. J Immunol 121: 2005-2013, 1978.
6. [6] Toews OB, Bergstresser PR, Streilein JW: Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124: 445-453, 1980.
7. [7] Schuler G, Steinman RM: Murine epidermal Langherans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161: 526-546, 1985.
8. [8] Romani N, Koide S, Crowley M, Witmer-Pack M. Livingstone AM, Fathman CO, Inaba K, Steinman RE: Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 169: 1169-1178, 1989.
9. [9] Streilein JW, Grammer SF: In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J Immunol 143: 3925-3933, 1989.
10. [10] Streilein JW, Grammer SF, Yoshikawa T, Demidem A, Vermeer M: Functional dichotomy between Langerhans cells that present antigen to naive and to memory effector T lymphocytes. Immunol Rev 117, 159-183, 1990.
11. [11] Streilein JW: Speculations on the immunopathogenesis of psoriasis: T cell violation of a keratinocyte sphere of influence. J Invest Dermatol 95: 205-215, 1990.
12. [12] Demidem A, Taylor JR, Grammer SF, Streilein JW: T lymphocyte activating properties of epidermal antigen presenting cells from normal and psoriatic skin. Evidence that psoriatic epidermal antigen presenting cells resemble cultured normal Langerhans cells. J Invest Dermatol 97: 454-460, 1991.
13. - antigen presenting cells. J Invest Dermatol 94: 485-491, 1990.
14. [14] Larsen CP, Ritche SC, Pearson TC, Linsley PS, Lowry RP: Functional expression of the costimulatory molecule, B7/ BB1, on murine dendritic cell populations. J Exp Med 176: 1215-1220, 1992.
15. [15] Teunissen MBM, Rongen HAH, Bos JD: Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activaion. J Immunol 152: 3400-3409, 1994.
16. [16] Heufler C, Schuler G: Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cell into potent immunostimulatory dendritic cells. J Exp Med 167: 700-705, 1988.
17. [17] Kampgen E, Koch K, Heufler C, Eggert A, Gill LL, Gillis S, Dower SK, Romani N, Schuler G: Understanding the dendritic cell lineage through a study of cytokine receptors. J Exp Med 179: 1767-1776, 1994.
18. [18] Xie Y, Streilein JW: Epidermal Langerhans cells from mice bearing a GM-CSF-producing mammary tumor display impaired functional properties in vitro. Exp Dermatol 3: 149, 1994.
19. [19] O'Doherty U, Gezetler PS, Swiggard WJ, Betijes M, Bhardway N, Steinman RM: Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82: 487-493, 1994.
20. [20] Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. J Immunol 89: 1398-1402, 1992.
21. [21] Kilgus O, Payer G, Schneiber S, Ebe A, Strohal R, Stingl G: In vivo cytokine expression in normal and perturbed murine skin - analysis by competitive quantitative polymerase chain reaction. J Invest Dermatol 100: 674-680, 1993.
22. [22] Ozawa H, Aiba S, Nakagawa S, Tagami H: The regulation of ICAM-I and B7 expression on murine Langerhans cells in vivo and in vitro. J Invest Dermatol 102: 586, 1994.
23. [23] Prinz JC, Grob B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G: T cell clones from psoriasis skin lesion can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 24: 593-598, 1994.
24. [24] Demidem AJ, Taylor JR, Grammer SF, Streilein JW: Effects of chloroquine on antigen-presenting functions of epidermal cells from normal and psoriatic skin. J Invest Dermatol 98: 181-186, 1992.